Kathleen O'Dell, CPhT

home / authors / kathleen-odell-cpht

Articles

A Call to Action for Evidence-based, Outcomes-driven Conflict Management Styles

A Call to Action for Evidence-based, Outcomes-driven Conflict Management Styles

Suzette Rovelsky, PharmD;Kathleen O'Dell, CPhT;Barbara Mason, PharmD;Lindsey Hunt, PharmD, BCPS
November 10th 2019

With expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.

Read More

Tech Duties Increase in Health Systems

Tech Duties Increase in Health Systems

Kathleen O'Dell, CPhT;Lindsay Kaster, PharmD, BCOP;Maribel Rincon, PharmD Candidate
September 19th 2019

Technicians pick up administrative tasks so pharmacists can spend more time on direct patient care.

Read More

Techs Can Assist With Smoking Cessation

Techs Can Assist With Smoking Cessation

Kathleen O'Dell, CPhT
April 25th 2019

They can help individualize programs, providing motivation and support to patients.

Read More

Latest Updated Articles

10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Gabapentin Differs From Pregabalin in Several Key Ways
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Semaglutide injecting pen on a white background, macro. Needle macro - Image credit: artmim | stock.adobe.com
Published: October 17th 2024 | Updated: October 23rd 2024
Concerns Linger About GLP-1 Agonists Despite Their Popularity
Vial with pneumococcal disease vaccine and syringe for injection.
Published: October 21st 2024 | Updated: October 23rd 2024
Pneumococcal 21-Valent Conjugate Vaccine Generates Positive Response in Adults at Increased Risk of Disease
Myasthenia Gravis disease blood test in doctor hand
Published: October 21st 2024 | Updated: October 23rd 2024
Myasthenia Gravis Negatively Impacts Patients and Care Partners Through Clinical, Financial Burdens
FDA Approval, Stelara, Biosimilar | Image Credit: Calin - stock.adobe.com
Published: October 1st 2024 | Updated: October 23rd 2024
FDA Approves Ustekinumab-Aauz as Biosimilar for Stelara